Tecentriq SC 1875 mg Injection USA | Bulk Oncology Exporter from India

Tecentriq SC 1875 mg Injection: The Next Generation of Subcutaneous Immunotherapy

Are you searching for a reliable Tecentriq SC 1875 mg injection exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced oncology treatments. We provide a high-authority, cold-chain-compliant supply chain serving the USA, UK, Australia, and South Africa, ensuring that groundbreaking subcutaneous immunotherapies reach healthcare providers with pharmaceutical-grade integrity and efficient global logistics.

Detailed Product Overview: What is Tecentriq SC 1875 mg?

Tecentriq SC 1875 mg (Atezolizumab and Hyaluronidase-tqjs), often marketed under the brand name Tecentriq Hybreza, is the subcutaneous (under-the-skin) formulation of the well-established PD-L1 inhibitor, Atezolizumab. It represents a major evolution in cancer care, offering the same clinical efficacy as the intravenous (IV) version but with significantly reduced administration time.

Manufactured by Roche/Genentech, this ready-to-use 15 mL vial contains 1875 mg of Atezolizumab combined with recombinant human hyaluronidase. For international B2B procurement, Tecentriq SC provides a more flexible, patient-centric treatment option that optimizes clinic resources and enhances the patient experience.

Primary Therapeutic Indications

Tecentriq SC 1875 mg is indicated for all adult indications previously approved for the IV formulation, including:

1. Non-Small Cell Lung Cancer (NSCLC): Adjuvant treatment following surgery and chemotherapy, or as a first-line treatment for metastatic NSCLC with high PD-L1 expression.

2. Small Cell Lung Cancer (SCLC): First-line treatment for extensive-stage SCLC in combination with chemotherapy.

3. Hepatocellular Carcinoma (HCC): In combination with bevacizumab for unresectable or metastatic liver cancer.

4. Alveolar Soft Part Sarcoma (ASPS): For adult and pediatric patients with unresectable or metastatic ASPS.

5. Melanoma: In combination with cobimetinib and vemurafenib for BRAF V600 mutation-positive disease.

Mechanism of Action: How Tecentriq SC Works

Tecentriq SC utilizes a dual-action mechanism to deliver efficient immunotherapy:

• PD-L1 Checkpoint Inhibition: Atezolizumab binds to the PD-L1 protein on tumor cells, preventing it from interacting with PD-1 and B7.1 receptors on T-cells. This reactivates the patient's immune system to recognize and destroy cancer cells.

• Hyaluronidase-tqjs Integration: The enzyme hyaluronidase temporarily breaks down hyaluronan in the subcutaneous tissue. This increases the permeability of the tissue, allowing the large volume (15 mL) of Atezolizumab to be absorbed rapidly into the systemic circulation.

  
  

Administration and Safety Guidelines

• Rapid Administration: Unlike the 30–60 minute IV infusion, Tecentriq SC is administered as a single 7-minute subcutaneous injection into the thigh.

• Professional Use Only: Must be administered by a healthcare professional. It is NOT for intravenous use.

• Storage & Handling: Must be refrigerated at 2°C to 8°C (36°F to 46°F). Prior to use, the vial should be allowed to reach room temperature (up to 25°C/77°F) for approximately 60 minutes.

• Key Precautions:

  • Immune-Mediated Reactions: Monitor for pneumonitis, colitis, hepatitis, and endocrinopathies.

  • Injection Site Reactions: While generally well-tolerated, monitor for redness or tenderness at the injection site.

  • Contraindications: Not for use in patients with known hypersensitivity to hyaluronidase.

Why Source Tecentriq SC from Ernest Oncology?

• Authentic Indian Exporter: Direct access to genuine Roche/Genentech inventory, ensuring 100% product authenticity and competitive bulk pricing.

• Patient-Centric Innovation: By supplying the SC formulation, we help clinics reduce patient chair time by up to 80%, increasing hospital throughput.

• Cold-Chain Integrity: Specialized logistics ensure the delicate monoclonal antibody remains at optimal temperatures during transit to the USA, UK, Australia, and South Africa.

• B2B Reliability: We specialize in fulfilling large-scale orders for government tenders, oncology centers, and regional medical distributors.